A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia
Author:
Affiliation:
1. From the Division of Hematology and Internal Medicine, Cancer Center Statistics Unit, Division of Hematopathology, and Division of Nuclear Medicine, Mayo Clinic, Rochester, MN; and Celgene, Warren, NJ.
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/101/7/2534/1264202/h80703002534.pdf
Reference47 articles.
1. Myelofibrosis with myeloid metaplasia.;Tefferi;N Engl J Med.,2000
2. Identification of “short-lived” and “long-lived” patients at presentation of idiopathic myelofibrosis.;Cervantes;Br J Haematol.,1997
3. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study.;Guardiola;Blood.,1999
4. Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis.;Anderson;Blood.,2001
5. rHuEpo for the treatment of anemia in myelofibrosis with myeloid metaplasia: experience in 6 patients and meta-analytical approach.;Rodriguez;Haematologica.,1998
Cited by 244 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors;Expert Opinion on Pharmacotherapy;2023-06-26
2. Primary myelofibrosis: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-02-06
3. Treatment Algorithm for Primary and Secondary Myelofibrosis;Pathogenesis and Treatment of Leukemia;2023
4. Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis;British Journal of Haematology;2022-09-12
5. Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3